Disney licenses characters to OpenAI
Wall Street Breakfast
00:00
Lilly's Weight-Loss Drug Trial Results
Kim Kahn summarizes Eli Lilly's Reda True Tide meeting primary and key secondary endpoints in a late-stage study.
Play episode from 02:09
Transcript
